Discontinuation report TRANSDERM-NITRO 0.4

Last updated on 2020-12-21 History
Report ID 119964
Drug Identification Number 00852384
Brand name TRANSDERM-NITRO 0.4
Common or Proper name Transderm Nitro 0.4
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) NITROGLYCERIN
Strength(s) 0.4MG
Dosage form(s) PATCH (EXTENDED RELEASE)
Route of administration TRANSDERMAL TRANSDERMAL
Packaging size 30
ATC code C01DA
ATC description VASODILATORS USED IN CARDIAC DISEASES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-10-31
Actual discontinuation date 2020-10-31
Remaining supply date 2020-10-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments The 0,6 mg will still be available until stock depletion or shelf life expiration (Aug 2021
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-12-21 French Compare
v3 2020-12-21 English Compare
v2 2020-07-10 French Compare
v1 2020-07-10 English Compare

Showing 1 to 4 of 4